[Research Progress of Circular RNA in Lung Cancer]

Xiangwei Ge1, Zhibo Zhang1, Xiaoyu Zhi1

  • 1Department of Oncology, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.

Insights

Circular RNAs (circRNAs) show promise as biomarkers for lung cancer diagnosis, treatment, and prognosis. These stable molecules regulate lung cancer progression through mechanisms like microRNA sponging.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer is a leading cause of cancer mortality globally, presenting significant diagnostic and therapeutic challenges.
  • The need for effective molecular markers and therapeutic targets in lung cancer is critical due to poor patient prognosis.
  • Circular RNAs (circRNAs) are emerging as important regulators in various biological processes, including cancer.

Purpose of the Study:

  • To review the current advancements in understanding the role of circRNAs in lung cancer.
  • To highlight the potential of circRNAs as diagnostic, therapeutic, and prognostic markers for lung cancer.
  • To summarize the diverse mechanisms by which circRNAs influence lung cancer development and progression.

Main Methods:

  • Literature review of recent studies on circRNAs in lung cancer.
  • Analysis of circRNA functions, including microRNA sponging and other regulatory roles.
  • Synthesis of findings related to circRNA's involvement in lung cancer diagnosis, treatment, and prognosis.

Main Results:

  • CircRNAs play a significant role in the regulation of lung cancer.
  • Mechanisms include microRNA sponging, affecting gene expression and cellular processes.
  • CircRNAs demonstrate potential as biomarkers for early diagnosis, treatment response, and patient prognosis.

Conclusions:

  • CircRNAs represent a promising area of research for improving lung cancer management.
  • Further investigation into circRNA functions can lead to novel diagnostic and therapeutic strategies.
  • CircRNAs hold potential for personalized medicine approaches in lung cancer treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.9K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.8K